Clinical Trials Directory

Trials / Completed

CompletedNCT02629146

Analgesic Effects of Midazolam in Human Volunteers

A Single Center, Prospective, Randomized, Double Blind, Placebo-controlled, Three-way Cross-over Study of the Analgesic Effects of Midazolam Versus Placebo With Fentanyl as an Active Control in Human Volunteers

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Wilhelminenspital Vienna · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study evaluates analgesic properties of midazolam compared to placebo and fentanyl. Each participant will receive all three drugs (midazolam, fentanyl, placebo) on three different occasions (study visits) and the effect on different pain stimuli will be tested.

Conditions

Interventions

TypeNameDescription
DRUGMidazolam
DRUGFentanyl
DRUGIsotonic saline

Timeline

Start date
2015-12-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2015-12-14
Last updated
2016-03-11

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT02629146. Inclusion in this directory is not an endorsement.

Analgesic Effects of Midazolam in Human Volunteers (NCT02629146) · Clinical Trials Directory